NCT05439291 Comparing Operative vs Non Operative Treatment for Pilonidal Disease
| NCT ID | NCT05439291 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Pilonidal Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2022-07-19 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2022-07-19 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation.
Eligibility Criteria
Inclusion Criteria: * Patients at Stanford Healthcare with pilonidal disease. * Patients over the age of 8yrs. Exclusion Criteria: * Inability to read, write or understand English \*\*\*or Spanish * Intellectual disability precluding the patient from being able to comprehend or respond to the questionnaire
Contact & Investigator
Bill Chiu, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT05439291 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, studying Pilonidal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05439291 currently recruiting?
Yes, NCT05439291 is actively recruiting participants. Contact the research team at bchiu@stanfordchildrens.org for enrollment information.
Where is the NCT05439291 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT05439291 clinical trial?
NCT05439291 is sponsored by Stanford University. The principal investigator is Bill Chiu, MD at Stanford University. The trial plans to enroll 400 participants.